← Insider buys
PCVX

Vaxcyte, Inc. · Healthcare

Director Robert Lorne Hopfner sold $10.4M of Vaxcyte, Inc.

Sold$10,355,466
$27.34Price
378,698Shares
−21%Stake

What PCVX did after the filing

Prices for PCVX after this filing aren't in yet.

Traded Mon, Feb 8. Filed Wed, Feb 10, 2:22 PM ET, during the session. Not investment advice.